Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Le, H. M. L. [1 ]
Pozas Perez, J. [2 ]
San Roman Gil, M. V. [2 ]
Serrano Domingo, J. J. [2 ]
Larkin, J. [1 ]
机构：
[1] NHS Fdn Trust, Med Dept, Royal Marsden Hosp, London, England
[2] Ramon y Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1158P
引用
收藏
页码：S691 / S691
页数：1
相关论文
共 50 条
  • [1] PREDICTING PRIMARY RESISTANCE AND EXPLORING MECHANISMS IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Long, Georjna A. O.
    Tang, Tracy
    Apfel, Abraham
    Paulucci, David
    Chasalow, Scott
    Tenney, Daniel
    Fusaro, Gina
    Schadendorf, Dirk
    Tawbi, Hussein
    Hodi, F. Stephen
    Thakkar, Pratik
    Larkin, James
    Wolchok, Jedd
    Wind-Rotolo, Megan
    Huang, Shu-Pang
    Mohr, Peter
    Robert, Caroline
    Hoeller, Christoph
    Grob, Jean-Jacque
    Gogas, Helen
    Weber, Jeffrey
    Chang, Han
    Moss, Rebecca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A639 - A640
  • [2] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Organ dysfunction (dys) and clinical outcomes in patients (pts) treated with immune checkpoint inhibitors (ICIs).
    Liu, Qi
    Sharon, Elad
    Zineh, Issam
    Xie, Diqiong
    Baxi, Shrujal S.
    Liu, Chao
    Zhi, Jizu
    Torres, Aracelis Z.
    Gossai, Anala
    Sridhara, Rajeshwari
    Booth, Brian
    Blumenthal, Gideon Michael
    Huang, Shiew-Mei
    Khozin, Sean
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Association of race with clinical outcomes in patients with advanced renal cell carcinoma (aRCC) treated with immune checkpoint inhibitors (ICIs)
    Choi, Yujin
    Yildirim, Ahmet
    Wei, Mengting
    Liu, Yuan
    Goswamy, Rohit Vivek
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne B.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Spillane, Susan
    Baxi, Shrujal
    Torres, Aracelis Z.
    Lenis, David
    Freedman, Andrew N.
    Mariotto, Angela B.
    Sharon, Elad
    ONCOLOGIST, 2020, 25 (11): : E1753 - E1762
  • [6] Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients
    Izawa, Naoki
    Shiokawa, Hisae
    Onuki, Risa
    Hamaji, Koki
    Furuya, Naoki
    Ohashi, Hiroyuki
    Nishi, Tomohiro
    Kasugai, Shigeru
    Arai, Hiroyuki
    Doi, Ayako
    Horie, Yoshiki
    Hirakawa, Mami
    Mizukami, Takuro
    Ogura, Takashi
    Tsuda, Takashi
    Sunakawa, Yu
    Nakajima, Takako
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Clinical outcome of immune related hepatitis (IrHep) in patients with advanced melanoma (AM) treated with single agent or combination immune checkpoint inhibitors (ICIs)
    Shah, N.
    Puthiamadathil, J.
    Serzan, M. T.
    Belouali, A.
    Kelly, W. J.
    Ma, B.
    Blackburn, M.
    Knoedler, A.
    OchoaGonzaelz, S.
    Janni, M.
    Madhavan, S.
    Gibney, G. T.
    Atkins, M. B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States
    Pan, Xianying
    Verma, Devashish
    Zhang, Jiayin
    Pathak, Raminder
    Monda, Stefano
    Ma, Xiaomei
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience
    Welaya, Karim
    Baran, Andrea M.
    Lekkala, Manidhar Reddy
    Sahasrabudhe, Deepak M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [10] PREVALENCE OF RHEUMATIC TOXICITIES IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Bruce, Alana
    Long, Georgina
    Menzies, Alexander
    Fernandes, Brian
    Joshua, Fredrick
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 37 - 38
12345